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Materials and Methods

Cell cultures, plasmids and antibodies
HCC cell lines HepG2, Hep3B, Bel7402, SMMC7721, HKCL2, HKCL9 SK-HEP1, and immortalized human liver cell L02, were purchased from American Type Culture Collection (ATCC), and were cultured according to the instructions from ATCC. L02 and HepG2 cells were transfected with the plasmids of full-length, wild-type of STK33 or the plain vector, while HKCL2 and SMMC7721 were transfected with the plasmids of STK33 shRNA or control shRNA, Lipofectamine 2000 (Invitrogen). They were selected by 0.8 mg/ml G418 (GIBCO BRL) for two weeks before cells with stable overexpression or knockdown of STK33 pool were gotten for the subsequent assays. Fipofectamine 2000 was used for transfection in c-Myc knockdown and cells were collected for relevant experiments after 72 hours. STK33 plasmid was transfected in to HepG2/c-Myc shRNA cells for STK33 rescue, the transfected cells were then selected by 0.8 mg/ml G418 (GIBCO BRL) plus 0.6 mg/ml Zeocin (Sigma) for two weeks until stable STK33 overexpression with c-Myc knockdown cells pool were obtained.
Target sequences of human STK33 shRNA1: 5'-TTAGCAGCAAGTTAATGGC-3', STK33 shRNA2: 5'-GCATTAAAGCAGCGTATC-3'; target sequence of human c-Myc shRNA: 5'-TTGCTCCTCTGCTTGGACG-3', and shRNA non-sense control target sequence: 5'-TGAGCAGGCGCATGTGCTG-3', all the shRNA plasmids were obtained from Thermo. The plasmid of STK33 (MHS1010-98053352) and c-Myc (MHS1010-57504) were purchased from Thermo. Primary antibodies to STK33 (ab110090), and cMyc (ab320720) were purchased from Abcam. Primary antibodies totubulin were purchased from Sigma. Second antibodies (anti-mouse IgG-HRP and anti-rabbit-HRP) were purchased from Sigma. MTT assay reagents were purchased from DingGuo Biotech. Alb-Cre-ER T2 mice was generated as previously described [17] . All animals were housed in laboratory animal facilities at the Second Military Medical University Medical Center under a standard 12-h light/dark cycle with access to chow and water as libitum.
Animals, Treatments, and Tissue Collection
Institutional Animal Care and Use Committee of the Second Military Medical University was approved for all experiments. All mice were euthanized after their experimental periods.
Eight-week-old male, STK33Tg flox/flox, Alb-ERT2-Cre mice were treated with TAM (6mg/mouse, IP), or with vehicle alone (corn oil, IP, referred as control) subcutaneously.
To detect hepatocyte proliferation and liver weight/body ratio and tumor burst ratio, mice were killed with CO 2 and livers were collected 7 days and 10 months after the injection, respectively. For BrdU detection, 1mg/Kg BrdU were peritoneal injected into mouse 2 hours before sacrifice.
Luciferase reporter assay
To evaluate c-Mc-dependent transcriptional activity, luciferase reporter assay was performed with a pair of luciferase reporter constructs hTRET-Luc and M4mintK-(Promega). Cells were transiently transfected in triplicate with one of these luciferase reporters and pCMV-β-galactosidase (Promega) using Lipofectamine 2000 (Invitrogen).
48h after transfection, luciferase activity was determined using the Luciferase Assay System Kit (Promega). β-galactosidase activity was determined using the Luminescent β-gal Detection Kit II (BD Clontech) as an internal control.
DNA preparation and detection of Ras point mutations
High molecular weight DNA was isolated from frozen HCC tumor samples or HCC cell lines. Selective amplification of the Ras gene sequence was done using a PCR technique.
The nucleotide sequences of the primers used are listed in supplemental Table 3 
